Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds

Details for Australian Patent Application No. 2007245495 (hide)

Owner Cancer Research Technology Limited Institute of Cancer Research: Royal Cancer Hospital (The) Astex Therapeutics Limited

Inventors Dijkstra, Harmen; Nourry, Arnaud; Menard, Delphine; Springer, Caroline Joy; Davies, Lawrence; Marais, Richard Malcolm; Niculescu-Duvaz, Ion; Niculescu-Duvaz, Dan

Agent FB Rice

Pub. Number AU-A-2007245495

PCT Pub. Number WO2007/125330

Priority 60/745,633 26.04.06 US; 0608268.9 26.04.06 GB

Filing date 26 April 2007

Wipo publication date 8 November 2007

International Classifications

C07D 471/04 (1970.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/125330 Priority application(s): WO2007/125330

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007245496-Amino-ethyl-amino-aryl (AEAA) compounds and their use

2007245494-Accessory for attenuated total internal reflectance (ATR) spectroscopy